These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25066760)

  • 121. HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates.
    Ranjpour M; Katare DP; Wajid S; Jain SK
    Anticancer Agents Med Chem; 2018; 18(8):1163-1176. PubMed ID: 29732980
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
    Zhang Q; He Y; Luo N; Patel SJ; Han Y; Gao R; Modak M; Carotta S; Haslinger C; Kind D; Peet GW; Zhong G; Lu S; Zhu W; Mao Y; Xiao M; Bergmann M; Hu X; Kerkar SP; Vogt AB; Pflanz S; Liu K; Peng J; Ren X; Zhang Z
    Cell; 2019 Oct; 179(4):829-845.e20. PubMed ID: 31675496
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma.
    Lu Z; Liu R; Wang Y; Jiao M; Li Z; Wang Z; Huang C; Shi G; Ke A; Wang L; Fu Y; Xia J; Wen H; Zhou J; Wang X; Ye D; Fan J; Chu Y; Cai J
    Hepatology; 2023 Mar; 77(3):745-759. PubMed ID: 35243663
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Caspase-2 deficiency accelerates chemically induced liver cancer in mice.
    Shalini S; Nikolic A; Wilson CH; Puccini J; Sladojevic N; Finnie J; Dorstyn L; Kumar S
    Cell Death Differ; 2016 Oct; 23(10):1727-36. PubMed ID: 27518436
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication.
    Nishida N; Kudo M
    Oncology; 2017; 92 Suppl 1():40-49. PubMed ID: 27764823
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma.
    Zhao F; Korangy F; Greten TF
    Dig Dis; 2012; 30(5):477-82. PubMed ID: 23108303
    [TBL] [Abstract][Full Text] [Related]  

  • 127. [Progress in regulatory T cells and hepatocellular carcinoma].
    Jiang S; Peng D; He L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):433-7. PubMed ID: 25931223
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Resistive Part of Impedance as a Possible Indicator of Hepatocellular Carcinoma.
    Salazar-Anguiano J; Chávez-López MG; Zúñiga-García V; Camacho J; Elías-Viñas D
    Arch Med Res; 2018 Feb; 49(2):89-93. PubMed ID: 29779755
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.
    Shetty S; Weston CJ; Oo YH; Westerlund N; Stamataki Z; Youster J; Hubscher SG; Salmi M; Jalkanen S; Lalor PF; Adams DH
    J Immunol; 2011 Apr; 186(7):4147-55. PubMed ID: 21368224
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity.
    Yang MC; Chang CP; Lei HY
    Lab Invest; 2010 Dec; 90(12):1782-93. PubMed ID: 20680008
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Anti-angiogenic therapy on hepatocellular carcinoma development and progression.
    Ishii Y; Sakamoto T; Ito R; Yanaga K
    J Surg Res; 2010 Jan; 158(1):69-76. PubMed ID: 19394651
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression.
    Hetta HF; Mekky MA; Zahran AM; Abdel-Malek MO; Ramadan HK; Shafik EA; Abbas WA; Abbas El-Masry M; Mohamed NA; Kamel AA; Marraiki N; Beshbishy AM; Batiha GE; Osman HA; Koneru G; El-Mokhtar MA
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32664587
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma.
    Tu JF; Pan HY; Ying XH; Lou J; Ji JS; Zou H
    Medicine (Baltimore); 2016 Mar; 95(13):e3220. PubMed ID: 27043690
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Regulatory B cells: origin, phenotype, and function.
    Rosser EC; Mauri C
    Immunity; 2015 Apr; 42(4):607-12. PubMed ID: 25902480
    [TBL] [Abstract][Full Text] [Related]  

  • 135. IFNγ
    Lee YH; Chuah S; Nguyen PHD; Lim CJ; Lai HLH; Wasser M; Chua C; Lim TKH; Leow WQ; Loh TJ; Wan WK; Pang YH; Soon G; Cheow PC; Kam JH; Iyer S; Kow A; Bonney GK; Chan CY; Chung A; Goh BKP; Zhai W; Chow PKH; Albani S; Liu H; Chew V
    Cancer Lett; 2023 Jan; 552():215977. PubMed ID: 36279983
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota.
    Fu H; Liu X; Jin L; Lang J; Hu Z; Mao W; Cheng C; Shou Q
    Food Funct; 2021 Nov; 12(21):10632-10643. PubMed ID: 34585698
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.
    Ouyang FZ; Wu RQ; Wei Y; Liu RX; Yang D; Xiao X; Zheng L; Li B; Lao XM; Kuang DM
    Nat Commun; 2016 Nov; 7():13453. PubMed ID: 27853178
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma.
    Carreres L; Mercey-Ressejac M; Kurma K; Ghelfi J; Fournier C; Manches O; Chuffart F; Rousseaux S; Minoves M; Decaens T; Lerat H; Macek Jilkova Z
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805134
    [TBL] [Abstract][Full Text] [Related]  

  • 139. DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor
    Lu Z; Xia YH; Zhao M; Zhang B; Dai WT; Ding L; Hu LX; Bi JL; Jiang GL
    Oncotarget; 2017 Aug; 8(33):54993-55002. PubMed ID: 28903397
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients.
    Wu J; Wang Y; Bai S; Sun H; Zhang J; Shu J; Wang Y; Tan M; Zhou L; Huang B; Pan Q; Sheng H
    Int J Med Sci; 2023; 20(2):267-277. PubMed ID: 36794164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.